Celularity and GX Acquisition Corp. Announce Merger Agreement to Create a Publicly Listed Leader in Allogeneic Cellular Therapy https://t.co/GNvdzv7aBx
Could not agree more! The truth is that chronic infection is a signal of a defective immune system either causal or consequential to the infection. Cellular immunotherapy offers a new angle for treatment. @celularity
#convalescentplasma in the absence of functional cellular immunity driven by #nk and #TCELL is like fuel put in the gas tank of a car without an engine. Now is the time for combination therapies @celularity
Vitamin D deficiency raises #COVID-19 infection risk by 77%, study finds
As many as one in four of the nearly 500 participants in the study were found to have less-than-optimal levels of vitamin D, the data showed.
https://t.co/ASlr6DFv2w
Celularity announces the activation of first California Clinical Trial Site following CIRM Grant Award to Advance Treatments for COVID-19 https://t.co/nwHw20Ou9X
With #COVID19 still claiming lives at an alarming level I am pleading that more attention be directed towards developing therapies @celularity @FansSorrento @StemCellMarket and that attention needs to include financial support.
Because of the products we offer, we always look at ourselves as becoming a part of your family. And on this day we want to let our family know we value them. Comment and let us know how we are doing.
Also, the CDC records any positive topical detection of Coronavirus as a case. A case does not equate to an illness from the virus and is a measure easily misinterpreted. A rise in cases is a function of increased testing. That’s all.